That’s why Vertex didn’t hire the people with extensive pain experience. Those candidates saw the writing on the wall with the data and asked too many questions during the interview process.Ouch!
Lots of people gave up good jobs to go sell this placebo.
The stock is down due to the placebo study results, that is not guru stuff, it’s Mr. Obvious stuff.you all are quite the investment gurus (or trolls)
what are you talking about "post-op"? LSR isn't for post operative use? that is acute pain (where data looks good).All will be fine…the study vs Placebo is one of if not the hardest pain patient to deal with post op.
how's this comment aging?Stock price is down over$100 per share since November. Should’ve backed up the truck before the House of Pain hit.
$516 was the high before the news, need to get back to that, meanwhile, go line up all your catering help for all those lunches, time for some serious big pharma call frequencyhow's this comment aging?
Come on share where you? Would help to understand why so jealous? I'm sure we will reconsider you for expansion or maybe for T1D or AMKD.$516 was the high before the news, need to get back to that, meanwhile, go line up all your catering help for all those lunches, time for some serious big pharma call frequency
